Streetbeat News

Stock Prices

CI

Eight financial analysts have recently shared their insights on Cigna Group (NYSE:CI), with opinions ranging from bullish to bearish. The average 12-month price target for CI is $348.25, with a high estimate of $372.00 and a low estimate of $327.00, marking a slight increase from the previous average of $347.00. Analyst actions include ratings from 'Buy' to 'Sector Perform' with adjustments to price targets. Cigna, a major player in health insurance and pharmacy benefit management, shows strong market performance with a notable revenue growth rate of 8.46% and impressive profitability metrics such as a net margin of 2.87% and ROE of 3.09%.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:01 pm

CI

Cigna Group (NYSE:CI) is scheduled to release its quarterly earnings report on February 2, 2024, with an expected EPS of $6.53. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the future. Despite past earnings beats, Cigna's stock has experienced mixed reactions, with a slight overall increase in share price over the last year. The upcoming earnings report is anticipated to be a significant indicator of the company's current performance and future outlook.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:00 pm

PDD

Over the past 5 years, PDD Holdings (NASDAQ:PDD) has achieved an average annual return of 33.09%, outperforming the market by 20.84%. With a current market capitalization of $169.20 billion, a $1000 investment in PDD 5 years ago would now be worth $4,231.86. This showcases the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:00 pm

MPWR

Monolithic Power Systems (NASDAQ:MPWR) has significantly outperformed the market with an annualized return of 35.57% over the past 5 years, turning a $1000 investment into $4,615.68. The company now has a market capitalization of $29.06 billion.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:00 pm

NVO

Four analysts have recently rated Novo Nordisk (NYSE:NVO) as somewhat bullish, with no change in sentiment over the last three months. The average 12-month price target for NVO has increased by 10% to $123.75, with adjustments from analysts at Cantor Fitzgerald and TD Cowen raising their targets. Novo Nordisk, a leader in diabetes care, has shown strong financial performance with a 28.89% revenue growth rate, a net margin of 38.27%, and an ROE of 24.5%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 6:00 pm

DGII

Digi International's shares surged following the announcement of their Q1 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 5:56 pm

CMPR

Cimpress Plc (NASDAQ:CMPR) shares surged after reporting Q2 earnings that exceeded expectations and announcing a $150 million share repurchase program. Earnings per share were $2.14, surpassing the $1.24 estimate, with sales of $921.36 million beating the $892.1 million forecast. The company's sales also showed a 9% increase from the previous year. CEO Robert Keane highlighted the company's focus on execution and profitability expansion.

Portfolio Pulse from Erica Kollmann

February 01, 2024 | 5:55 pm

GOOGL

IWM

LULU

NKE

QQQ

SPY

Following the Federal Reserve's indication of no expected rate cuts in early 2024, U.S. equity markets, particularly technology stocks, consumer goods, and small caps, experienced significant downturns. The S&P 500, Nasdaq, and Russell 2000 indexes all closed lower, with corresponding ETFs SPY, QQQ, and IWM reflecting these declines. The Fed's stance, seen as a slight hawkish turn, has led to concerns over a potential policy mistake, impacting companies reliant on capital market borrowing and consumer credit. Notably, Alphabet's shares dropped 7.5%, while Lululemon and Nike also saw declines. The iShares U.S. Technology ETF and the Consumer Discretionary Select Sector SPDR Fund experienced downturns but showed signs of recovery the following day.

Portfolio Pulse from Neil Dennis

February 01, 2024 | 5:55 pm

VSTO

Vista Outdoor shares are trading higher following the announcement of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 5:55 pm

EVER

EverQuote's stock price increased following B. Riley Securities' decision to maintain a Buy rating and raise its price target from $14 to $18.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 5:54 pm